Amarin Corp Plc (AMRN)

[biowreck]

Stockboy...even with existing FDA approvad label, insurance has been an issue in some form or another, whether it’s outright coverage or tier level. Your biggest patient population oppty is on Medicare and until expanded label...I don’t see exponential growth short term. So yes 3-4 years could be how much time it takes to see the 2b revenue market some are forecasting, as well as significant pps appreciation. Generics still continue to be the preferred drug by many carriers...whether it’s in the best interest of the patient or not. We need this FDA expanded label yesterday to have a rats ass chance to see exponential script growth in 2019, and getting it in 3Q or 4Q is late. As a long term holder, i’d Much prefer a 35-50$ buyoutnow, rather than the so called lotto prize of $100 to whatever sometime in the future